Previous Article | Next Article ![]()
Infection and Immunity, December 2001, p. 7663-7670, Vol. 69, No. 12
Institut für Experimentelle und
Klinische Pharmakologie und Toxikologie der
Albert-Ludwigs-Universität Freiburg, D-79104
Freiburg,1 EMBL, D-69117
Heidelberg,2 and Biozentrum N260,
Pharmakologisches Institut für Naturwissenschaftler, Johann
Wolfgang Goethe-Universität, D-60439
Frankfurt,3 Germany
Received 25 June 2001/Returned for modification 7 August
2001/Accepted 5 September 2001
Bordetella dermonecrotic toxin (DNT) catalyzes the
transglutamination of glutamine-63/61 of Rho GTPases, thereby
constitutively activating Rho proteins. Here we identified second
substrates for transglutamination of RhoA by DNT. The enzymatically
active fragment of DNT (residues 1136 to 1451,
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7663-7670.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Lysine and Polyamines Are Substrates for
Transglutamination of Rho by the Bordetella
Dermonecrotic Toxin
DNT) induced the
incorporation of L-[14C]lysine in RhoA in a
concentration-dependent manner. Also, Rac and Cdc42, but not Ras, were
transglutaminated with lysine by
DNT. Transglutamination of the
GTPase with L-lysine inhibited intrinsic and
Rho-GAP-stimulated GTP hydrolysis of RhoA. In contrast to lysine,
treatment of RhoA with alanine, arginine, and glutamine were not able
to substitute for lysine in the transglutamination reaction. DNT
increased the incorporation of L-[14C]lysine
into embryonic bovine lung cells. Microinjection of GST-RhoA together
with the enzymatically active DNT fragment into
Xenopus oocytes, subsequent affinity purification of
modified GST-RhoA, and mass spectrometry identified attachment of
putrescine or spermidine at glutamine-63 of RhoA. A comparison of
putrescine, spermidine, and lysine as substrates for DNT-induced
transglutamination of RhoA revealed that lysine is a preferred second
substrate at least in vitro.
*
Corresponding author. Mailing address: Institut
für Experimentelle und Klinische Pharmakologie und Toxikologie,
Albert-Ludwigs-Universität Freiburg, Albert-Str. 25, D-79104
Freiburg, Germany. Phone: 49-761-203-5301. Fax: 49-761-203-5311. E-mail: aktories{at}uni-freiburg.de. E-mail: gudschmi{at}uni-freiburg.de.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»